Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $250.5K | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $88.1K | $125.0K | $42.9K | $102.3K | $147.3K | $0 |
| Gross profit | $0 | −$7.3K | −$88.1K | $125.6K | −$42.9K | −$102.0K | −$147.0K | $0 |
| Gross margin | — | — | — | 50.1% | — | — | — | — |
| R&D | $0 | $343.7K | $2.5M | $1.7M | $0 | $1.0M | $8.3K | $0 |
| Operating income | −$38.1K | −$45.0K | −$4.4M | −$4.4M | −$856.0K | −$3.2M | −$610.0K | −$144.0K |
| EBITDA | −$38.1K | −$45.0K | −$3.9M | −$4.2M | −$839.0K | −$3.5M | −$463.0K | $3.3K |
| Net income | −$38.1K | −$44.1K | −$5.1M | −$4.3M | −$2.7M | −$10.6M | −$1.1M | −$107.0K |
| Net margin | — | — | — | -1735.1% | — | — | — | — |
| EPS (diluted) | -0.01 | -0.01 | -0.16 | -0.10 | -0.05 | -0.10 | -0.01 | -0.00 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds FLURF.
No tracked institution reports a position in FLURF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-04-23 | 1-for-15reverse |
No one on the platform has traded FLURF yet.
| $518242 |
| — |
| LAXAFLaxai Pharma, Ltd. | $0.00 | +0.00% | $475341 | — |
| LNDZFEvome Medical Technologies Inc. | $0.00 | +0.00% | $5981 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.